Blueprint Medicines Corporation
BPMC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$67 | -$507 | -$558 | -$644 |
| Dep. & Amort. | $16 | $12 | $12 | $6 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $109 | $93 | $99 | $92 |
| Change in WC | $0 | -$41 | -$54 | -$24 |
| Other Non-Cash | -$251 | $7 | -$2 | $270 |
| Operating Cash Flow | -$193 | -$437 | -$502 | -$299 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$16 | -$9 | -$261 |
| Net Acquisitions | $0 | $0 | $0 | $258 |
| Inv. Purchases | -$966 | -$766 | -$490 | -$655 |
| Inv. Sales/Matur. | $924 | $1,056 | $349 | $691 |
| Other Inv. Act. | $0 | $0 | -$0 | -$258 |
| Investing Cash Flow | -$48 | $274 | -$150 | -$226 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $147 | $98 | $138 | $0 |
| Stock Issued | $49 | $0 | $8 | $51 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $77 | -$0 | $424 | $51 |
| Financing Cash Flow | $273 | $119 | $562 | $51 |
| Forex Effect | -$1 | $0 | -$0 | -$1 |
| Net Chg. in Cash | $32 | -$43 | -$90 | -$475 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82 | $125 | $215 | $690 |
| End Cash | $114 | $82 | $125 | $215 |
| Free Cash Flow | -$197 | -$453 | -$511 | -$560 |